Beta Blocker Interruption After Uncomplicated Myocardial Infarction

PHASE4CompletedINTERVENTIONAL
Enrollment

3,700

Participants

Timeline

Start Date

August 29, 2018

Primary Completion Date

October 31, 2023

Study Completion Date

October 31, 2023

Conditions
Myocardial Infarction
Interventions
DRUG

Beta-blockers withdrawal

withdrawal of all type of betablockers

DRUG

Continuation of the Betablockers (βB) treatment

Use Betablockers treatment

Trial Locations (1)

75013

Institut de Cardiologie - USIC - Hôpital Pitié-Salpêtrière, Paris

All Listed Sponsors
collaborator

Groupe Hospitalier Pitie-Salpetriere

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT03498066 - Beta Blocker Interruption After Uncomplicated Myocardial Infarction | Biotech Hunter | Biotech Hunter